EA5142 Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (ANVIL)

June 30, 2018
https://clinicaltrials.gov/ct2/show/NCT02595944
Cancer - Lung
Principal Investigator: Ding Wang, MD
CANCER, STAGE 1, STAGE 1B, STAGE 2, STAGE 3, STAGE 3A, LUNG, LUNG CANCER, NON-SMALL CELL, NON SMALL CELL
Accepting Participants